FLC Capital Advisors
Source: SEC Form 13F · as of Mar 2026FLC Capital Advisors holds 16 biotech & pharma companies tracked by BioSniper, totaling $24.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$24.3M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 87,402 | $10.5M |
| JNJJOHNSON & JOHNSON | 13,757 | $3.4M |
| PMPhilip Morris International Inc | 13,785 | $2.3M |
| PFEPFIZER INC | 68,852 | $1.9M |
| ABBVAbbVie Inc. | 5,262 | $1.1M |
| LLYELI LILLY & Co | 1,111 | $1.0M |
| AMGNAMGEN INC | 2,086 | $734K |
| NVSNovartis AG | 3,066 | $468K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 8,443 | $466K |
| ABTABBOTT LABORATORIES | 3,963 | $407K |
| NVONovo Nordisk A/S | 10,624 | $390K |
| GILDGILEAD SCIENCES, INC. | 2,696 | $376K |
| CORCencora Inc. | 1,048 | $329K |
| MCKMcKesson Corporation | 350 | $303K |
| BMYBRISTOL MYERS SQUIBB CO | 4,726 | $287K |
| SNYSanofi | 5,543 | $267K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.